https://www.avient.com/sites/default/files/resources/PolyOne%2520IR%2520Presentation%2520-%2520RW%2520Baird%2520Global%2520Industrial%2520Conference.pdf
Use of Non-GAAP Measures
4POLYONE CORPORATION
INPUTS
FORMULATION
EXPERTISE
SERVICE VALUE
Base resins
Additives
Modifiers
Pigments
Expertise in
Polymer
Materials,
Services and
Solutions
OEMs
Brand Owners
Processers
Assemblers
InVisiO
SM
Color
Services
IQ Design Labs
LSS Customer
First
Specialty products & services
What We Do
Driving customer value
5POLYONE CORPORATION
$0.13
$0.68
$0.82
$1.00
$1.31
$1.80
$1.96
$2.06
2009 2010 2011 2012 2013 2014 2015 2016*
*Recast for DSS in discontinued operations
PolyOne At a Glance
Performance
Products &
Solutions
22%
PolyOne
Distribution
34%
Specialty
Engineered
Materials
18%
Color
Additives
and Inks
26%
2016
Revenue by
Segment
Adjusted Earnings per Share
2016
Revenue by
Geography
United
States
60%
Europe
15%
Latin
America
9%
Canada
7%
Asia
10%
6POLYONE CORPORATION
2%
43%
76%
0%
20%
40%
60%
80%
100%
2005 2010 3Q 2017
%
o
f
O
p
e
ra
ti
n
g
I
n
c
o
m
e
*
*Operating Income excludes corporate charges and special items **LTM 3Q 2017
Specialty OI $5M $87M $275M**
JV’s Performance Products & Solutions
Specialty MixDistribution
Mix Shift Highlights Specialty Transformation
Distribution and Contract
Manufacturing Businesses
7POLYONE CORPORATION
2014 2015 2016 2017
2014 2015 2016 2017
Driving Growth
• Refreshed training curriculum
for sales force
• Upgraded capabilities to generate
and capture new business leads
• Expanded R&D resources to focus
on key platforms
2014 2015 2016 2017
Investment in Commercial Resources
Commercial Resource Additions*
Total Sales CallsSales Opportunity Funnel (in billions)
*Sales, Marketing & Technology headcount
8POLYONE CORPORATION
*ROIC is defined as TTM adjusted OI after tax divided by the sum of average debt and equity less cash over a 5 quarter period
Proof of Performance & 2020 Platinum Vision
20%+
20%+
12 - 14%
6.5 – 7.5%
15%
Consistently Deliver Double Digit Annual EPS Growth
2006 YTD 2017 2020
“Where we were” “Where we are” Platinum Vision
ROIC* 5.0% 13.8%
Operating Income % of Sales
Color, Additives & Inks 1.7% 16.4%
Specialty Engineered Materials 1.1% 13.1%
Performance Products & Solutions 5.5% 11.4%
Distribution 2.6% 6.6%
9POLYONE CORPORATION
$50
$116
$137
$0
$40
$80
$120
$160
$200
2012 2014 2016 2017
10.8%
11.3%
12.9%
13.8%
10.0%
11.0%
12.0%
13.0%
14.0%
15.0%
2012 2014 2016 3Q 2017 2020
Platinum
Vision
Free Cash Flow
(in millions)
ROIC*
*ROIC is defined as TTM adjusted OI after tax divided by the sum of average debt and equity less cash over a 5 quarter period
Free Cash Flow and Improving Returns
15.0%
>$200
10POLYONE CORPORATION
$0.16
$0.20
$0.24
$0.32
$0.40
$0.48
$0.54
$0.70
$-
$0.10
$0.20
$0.30
$0.40
$0.50
$0.60
$0.70
$0.80
$0.90
$1.00
2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
Annual Dividend
7 Consecutive Years of Increased Dividends
3-Year Dividend Plan
Announced 30% increase
to dividend in October
2017, reflecting strong and
sustainable cash flow as
well as confidence in future
earnings growth
Expect to increase annual
dividend 60% or more
cumulatively over next
three years
11POLYONE CORPORATION
$767M
Returning Cash to Shareholders
$0
$150
$300
$450
$600
$750
2011 2012 2013 2014 2015 2016 3Q
2017
Cumulative Share Repurchases
(in millions)
Since 2011, we have
returned over $950 million
to shareholders
$192 million returned
through dividends
$767 million returned
through share
repurchases
Have repurchased 20.8
million shares since
early 2013
$767M
12POLYONE CORPORATION
Expanding our sales,
marketing, and
technical capabilities
Investing in
operational and LSS
initiatives
~60 - 70% of capital
expenditures fund
growth initiatives
Organic
Growth
Acquisitions
Share
Repurchases
Dividends
Targets that expand
our:
• Specialty
offerings
• End market
presence
• Geographic
breadth
Growth synergies
Adjacent material
solutions
Repurchased 2.0
million shares
YTD 2017
Repurchased 20.8
million shares
since early 2013
6.5 million shares
are available for
repurchase under
the current
authorization
Increased annual
dividend by 30% to
$0.70 per share,
representing the
seventh consecutive
year of dividend
growth
Free Cash Flow and Strong Balance Sheet
Fund Investment / Shareholder Return
13POLYONE CORPORATION
*Specialty Platform revenue from products introduced in last five years
Vitality Index Progression*
12%
42%
2006 2016
Target ≥ 35%
Innovation Drives Earnings Growth
Innovation Pipeline Potential
$20
$54
2006 2016
Research & Development Spending
($ millions)
Phase 1
Frame
Opportunity
12 Projects
Phase 2
Build Business
Case
10 Projects
Phase 3
Prototype
21 Projects
Phase 4
Scale-up &
Test Market
19 Projects
Phase 5
Commercial
Launch
10 Projects
$500 Million $1.4 Billion $700 Million
Total Specialty Addressable Market of over $2.6 Billion
14POLYONE CORPORATION
Key Innovation Growth Drivers
Composites
Barrier Additive
Technology
Fiber Colorants
Flame Retardant
Polymers
Increasing regulatory drive for halogen replacements
$400m addressable market
Drive to prevent oxygen, light and UV rays from affecting contents in PET
packaging, extending shelf life
$200m addressable market
60% of world fiber consumption is synthetic, need to simplify manufacturing
and eliminate waste
$300m addressable market
Polymer formulation and process engineering create a pipeline for next
generation materials
Drive to replace aluminum and steel with plastics without
compromising on strength
15POLYONE CORPORATION
Providing LSS services to
small/medium sized customers
54% of associates trained in LSS, with over
125 active black belts
Have trained over 30 customers in
LSS methodology
Providing training in Customer Centric
Selling Skills with customers
Providing Industrial design and color
services to small/medium sized
customers
On time delivery above 95%
Strengthening relationships:
Customer First Through World-Class Service
16POLYONE CORPORATION
Addressable market exceeds $40 billion
Strong performance demonstrates that our strategy and execution are
working
Megatrends and emerging opportunities align with strengths
Innovation and services provide differentiation, incremental pricing
power and competitive advantage
Strategic reinvestment for growth while returning cash to shareholders
Strong and proven management team driving growth
and performance
Why Invest In PolyOne?
https://www.avient.com/sites/default/files/resources/POL%2520Gabelli%2520IR%2520Presentation%2520w%2520Non-GAAP%252003%252020%25202014.pdf
Use of Non-GAAP Measures
Page 3
PolyOne Commodity to Specialty Transformation
Page 4
• Continue specialty
transformation
• Targeting $2.50
Adjusted EPS by
2015, nearly
double 2013 EPS
• Drive double digit
operating income
and adjusted EPS
growth
• 17 consecutive
quarters of double-
digit adjusted EPS
growth
• Shift to faster
growing, high
margin, less cyclical
end markets
• Key acquisitions
propel current and
future growth, as
well as margin
expansion
• Established
aggressive 2015
targets
• Steve Newlin
Appointed,
Chairman, President
and CEO
• New leadership
team appointed
• Implementation of
four pillar strategy
• Focus on value
based selling,
investment in
commercial
resources and
innovation to drive
transformation
• Volume driven,
commodity
producer
• Heavily tied to
cyclical end markets
• Performance largely
dependent on non-
controlling joint
ventures
2000-2005 2006 - 2009 2010 – 2013 2014 and beyond
-150.00%
-50.00%
50.00%
150.00%
250.00%
350.00%
PolyOne S&P 500 Russell 2000 Dow Jones Chemical
All time high of
$38.38
March 7th, 2014
• 17 consecutive quarters of
double digit EPS growth
• 49% CAGR adjusted EPS
expansion 2006-2013
• 2013 stock price increased
73% versus 30% growth in the
S&P
• More than seven fold increase in
market cap: $0.5b $3.6b
Strategy and Execution Drive Results
Page 5
Appliance
4%
Building &
Construction
13%
Wire & Cable
9%
Electrical &
Electronics
5%
Consumer
10%Packaging
16%
Industrial
12%
HealthCare
11%
Transportation
18%
Misc.
2%
United
States
66%
Europe
14%
Canada
7%
Asia
6%
Latin
America
7%
PP&S
20%
Specialty
53%
Distribution
27%
0.12
0.27 0.21
0.13
0.68
0.82
1.00
1.31
2.50
$0.00
$0.25
$0.50
$0.75
$1.00
$1.25
$1.50
$1.75
$2.00
$2.25
$2.50
2006 2007 2008 2009 2010 2011 2012 2013 2015
Target
A
dj
us
te
d
Ea
rn
in
gs
P
er
S
ha
re
2013 Revenues: $3.8 Billion
End Markets
2013 Revenues: $3.8 Billion
EPS
Page 6
PolyOne
At A Glance
Old
PolyOne Transformation
*Operating Income excludes corporate charges and special items
2%
34%
43%
62%
65-
75%
0%
20%
40%
60%
80%
100%
2005 2008 2010 2013 2015
%
o
f O
pe
ra
ti
ng
In
co
m
e*
JV's Performance Products & Solutions Distribution Specialty
Specialty OI $5M $46M $87M $195M Target
Mix Shift Highlights Specialty Transformation
2015
Target
Page 7
2006 2013 2015
“Where we were” “Where we are” Target
1) Operating Income %
Specialty:
Global Color, Additives & Inks 1.7% 12.2% 12 – 16%
Global Specialty Engineered
Materials 1.1% 9.3% 12 – 16%
Designed Structures & Solutions -- 5.6% 8 – 10%
Performance Products &
Solutions 5.4% 7.2% 9 – 12%
Distribution 2.6% 5.9% 6 – 7.5%
2) Specialty Platform % of
Operating Income 6.0% 62% 65 – 75%
3) ROIC* (after-tax) 5.0% 9.1% 15%
4) Adjusted EPS Growth N/A 31%
Double Digit
Expansion
Proof of Performance & 2015 Goals
*ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period
Page 8
Bridge To $2.50 Adjusted EPS By 2015
2015 EPS: $2.50
2013 EPS: $1.31
Mid single digit
revenue CAGR
Page 9
Mergers & Acquisitions
Spartech accretion
Incremental share buybacks
Ongoing LSS Programs
(50-100 bps/yr)
Accelerated Innovation &
Mix Improvement
Innovation Drives Earnings Growth
$20.3
$52.3
2006 2013
Research & Development
Spending
($ millions)
Specialty Platform
Vitality Index Progression*
*Percentage of Specialty Platform revenue from products introduced in last five years
Page 10
14.3%
30.7%
2006 2013
Specialty Platform
Gross Margin %
19.5%
43.0%
2006 2013
Healthcare
Consumer
Packaging and Additive Technology
Transportation
Page 11
Unique and Innovative Solutions that Help
Customers Win
https://www.dropbox.com/sh/dwe4t8aacvhb8ui/uD3p_bdglP/Presentation revise pics/GLS Beverage can closure XO 2.jpg
https://www.dropbox.com/sh/dwe4t8aacvhb8ui/-YgkycKypw/Anti-Counterfeiting release & images/GN1979.JPG
Net Debt / EBITDA* = 1.8x
$48
$317
$600
$0
$100
$200
$300
$400
$500
$600
$700
$800
2015 2020 2023
Significant Debt Maturities
As of December 31, 2013
($ millions)
Page 12
Coupon Rates: 7.500% 7.375% 5.250%
Debt Maturities & Pension Funding – 12/31/13
*TTM 12/31/2013 ** includes US-qualified plans only
60%
100%
20%
30%
40%
50%
60%
70%
80%
90%
100%
2008 2013
Pension Funding**
As of December 31, 2013
Free Cash Flow and Strong Balance Sheet Fund Investment
• Targets that expand our:
• Specialty offerings
• End market presence
• Geographic footprint
• Operating Margin
• Synergy opportunities
• Adjacent material solutions
• Expanding our sales,
marketing, and technical
capabilities
• Investing in operational and
LSS initiatives (including
synergy capture)
• Manufacturing alignment Organic
Growth
Share
Repurchases
Dividends
Acquisitions
Page 13
$0.16
$0.20
$0.24
$0.32
$0.00
$0.10
$0.20
$0.30
$0.40
2011 2012 2013 2014
Annual Dividend
• Repurchased ~5 million
shares in 2013
• 15 million shares
are available for
repurchase under
the current
authorization
The New PolyOne: A Specialty Growth Company
2015 Target: $2.50 Adjusted EPS
Why Invest In PolyOne?
Strong past performance demonstrates that our strategy and
execution are working
• Megatrends align with our strengths
• Innovation and services provide differentiation, incremental
pricing power, and competitive advantage
• Strong and proven management team driving growth and
performance
• Addressable market exceeds $40 billion
Page 14
1
Schedule I
Reconciliation of Non-GAAP Financial Measures (Unaudited)
(Dollars in millions, except per share data)
Below is a reconciliation of non-GAAP financial measures to the most directly comparable measures calculated and presented
in accordance with U.S.
PolyOne Investor Presentation��Gabelli & Company �5th Annual Specialty Chemical Conference�March 20, 2014�
Forward – Looking Statements
Use of Non-GAAP Measures
PolyOne Commodity to Specialty Transformation
Strategy and Execution Drive Results
PolyOne�At A Glance
Mix Shift Highlights Specialty Transformation
Proof of Performance & 2015 Goals
Bridge To $2.50 Adjusted EPS By 2015
Innovation Drives Earnings Growth
Unique and Innovative Solutions that Help Customers Win
Debt Maturities & Pension Funding – 12/31/13
Free Cash Flow and Strong Balance Sheet Fund Investment
Why Invest In PolyOne?
https://www.avient.com/sites/default/files/resources/POL%2520IR%2520Presentation%2520Wells%2520Fargo%252005%252008%25202014%2520w%2520non%2520GAAP.pdf
Use of Non-GAAP Measures
Page 3
PolyOne Commodity to Specialty Transformation
• Volume driven,
commodity producer
• Heavily tied to cyclical
end markets
• Performance largely
dependent on non-
controlling joint
ventures
2000-2005 2006 - 2009 2010 – 2014 2015 and beyond
• Steve Newlin
appointed, Chairman,
President and CEO
• New leadership team
appointed
• Implementation of
four pillar strategy
• Focus on value based
selling, investment in
commercial resources
and innovation to drive
transformation
• 18 consecutive
quarters of double-
digit adjusted EPS
growth
• Shift to faster growing,
high margin, less
cyclical end markets
• Key acquisitions propel
current and future
growth, as well as
margin expansion
• Established aggressive
2015 targets
• Continue specialty
transformation
• Targeting $2.50
Adjusted EPS by 2015,
nearly double 2013
EPS
• Drive double digit
operating income and
adjusted EPS growth
Confirmation of Our Strategy
The World’s Premier Provider of Specialized
Polymer Materials, Services and Solutions
Specialization Globalization
Operational
Excellence
Commercial
Excellence
-150.00%
-50.00%
50.00%
150.00%
250.00%
350.00%
450.00%
PolyOne S&P 500 Russell 2000 Dow Jones Chemical
All time high of
$39.28
April 4th, 2014
• 18 consecutive quarters of
double digit EPS growth
• 49% CAGR adjusted EPS
expansion 2006-2013
• 2013 stock price increased
73% versus 30% growth in the
S&P
• More than seven fold increase in
market cap: $0.5b $3.6b
Strategy and Execution Drive Results
Page 6
Appliance
4%
Building &
Construction
13%
Wire & Cable
9%
Electrical &
Electronics
5%
Consumer
10%Packaging
16%
Industrial
12%
HealthCare
11%
Transportation
18%
Misc.
2%
0.12
0.27 0.21
0.13
0.68
0.82
1.00
1.31
2.50
$0.00
$0.25
$0.50
$0.75
$1.00
$1.25
$1.50
$1.75
$2.00
$2.25
$2.50
2006 2007 2008 2009 2010 2011 2012 2013 2015
Target
A
dj
us
te
d
Ea
rn
in
gs
P
er
S
ha
re
2013 Revenues: $3.8 Billion
End Markets
2013 Revenues: $3.8 Billion
EPS
Page 7
PolyOne
At A Glance
United
States
67%
Europe
14%
Canada
7% Asia6%
Latin
America
6%
Specialty
54%
PP&S
18%
Distribution
28%
Mix Shift Highlights Specialty Transformation
Page 8
Old
PolyOne Transformation
*Operating Income excludes corporate charges and special items
2%
34% 43%
62% 64%
0%
20%
40%
60%
80%
100%
2005 2008 2010 2013 Q1 2014 2015
%
o
f
O
pe
ra
tin
g
In
co
m
e*
JV's Performance Products & Solutions Distribution Specialty
65-75%
Specialty OI $5M $46M $87M $195M $60M Target
2015
Target
Proof of Performance & 2015 Goals
Page 9
2006 Q1 2014 2015
“Where we were” “Where we are” Target
1) Operating Income %
Specialty:
Global Color, Additives & Inks 1.7% 13.8% 12 – 16%
Global Specialty Engineered
Materials 1.1% 11.6% 12 – 16%
Designed Structures & Solutions -- 6.5% 8 – 10%
Performance Products &
Solutions 5.5% 7.7% 9 – 12%
Distribution 2.6% 6.1% 6 – 7.5%
2) Specialty Platform % of
Operating Income 6.0% 64% 65 – 75%
3) ROIC* (after-tax) 5.0% 9.4% 15%
4) Adjusted EPS Growth N/A 42% Double DigitExpansion
*ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period
Bridge to $2.50 Adjusted EPS by 2015
2015 EPS: $2.50
2013 EPS: $1.31
Continued Gross Margin
Expansion
Mergers & Acquisitions
Spartech Accretion
Incremental share buybacks
Ongoing LSS Programs
(50-100 bps/yr)
Accelerated Innovation
& Mix Improvement Several Levers to
Drive Growth
Mid single digit revenue CAGR
Innovation Drives Earnings Growth
$20.3
$52.3
2006 2013
Research & Development
Spending
($ millions)
Specialty Platform
Vitality Index Progression*
*Percentage of Specialty Platform revenue from products introduced in last five years
Page 11
14.3%
30.7%
2006 2013
Specialty Platform
Gross Margin %
19.5%
42.0%
2006 Q1 2014
Healthcare
Consumer
Packaging and Additive Technology
Transportation
Page 12
Unique and Innovative Solutions
https://www.dropbox.com/sh/dwe4t8aacvhb8ui/uD3p_bdglP/Presentation revise pics/GLS Beverage can closure XO 2.jpg
https://www.dropbox.com/sh/dwe4t8aacvhb8ui/-YgkycKypw/Anti-Counterfeiting release & images/GN1979.JPG
60%
100%
20%
30%
40%
50%
60%
70%
80%
90%
100%
2008 2014
Pension Funding**
As of March 31, 2014
Debt Maturities & Pension Funding – 3/31/14
Net Debt / EBITDA* = 1.9x
$48
$317
$600
$0
$100
$200
$300
$400
$500
$600
$700
$800
2015 2020 2023
Debt Maturities
As of March 31, 2014
($ millions)
Coupon Rates: 7.500% 7.375% 5.250%
** includes US-qualified pension plans only *TTM 3/31/2014
Free Cash Flow and Strong Balance Sheet
Fund Investment / Shareholder Return
$0.16
$0.20
$0.24
$0.32
$0.10
$0.20
$0.30
$0.40
2011 2012 2013 2014
Annual Dividend
Expanding our sales,
marketing, and technical
capabilities
Investing in operational and
initiatives that drive
profitability growth
Manufacturing realignment
Targets that expand our:
• Specialty offerings
• End market presence
• Geographic footprint
• Operating Margin
Synergy opportunities
Adjacent material solutions
Repurchased 1.4 million
shares in Q1 2014
Repurchased 6.4 million
shares since April 2013
13.6 million shares are
available for repurchase
under the current
authorization
Organic
Growth
Acquisitions
Share
Repurchases
Dividends
The New PolyOne: A Specialty Growth Company
Why Invest In PolyOne?
Strong past performance demonstrates that our strategy and execution
are working
Megatrends and emerging opportunities align with our strengths
Innovation and services provide differentiation, incremental pricing
power, and competitive advantage
Strong and proven management team driving growth and performance
Addressable market exceeds $40 billion
Schedule I
Reconciliation of Non-GAAP Financial Measures (Unaudited)
(Dollars in millions, except per share data)
Below is a reconciliation of non-GAAP financial measures to the most directly comparable measures calculated and
presented in accordance with U.S.
���PolyOne Investor Presentation�5th Annual Wells Fargo�Industrial and Construction Conference �May 8, 2014 ��
Forward – Looking Statements
Use of Non-GAAP Measures
PolyOne Commodity to Specialty Transformation
Confirmation of Our Strategy
Strategy and Execution Drive Results
PolyOne�At A Glance
Mix Shift Highlights Specialty Transformation
Proof of Performance & 2015 Goals
Bridge to $2.50 Adjusted EPS by 2015
Innovation Drives Earnings Growth
Unique and Innovative Solutions
Debt Maturities & Pension Funding – 3/31/14
Free Cash Flow and Strong Balance Sheet �Fund Investment / Shareholder Return
Why Invest In PolyOne?
https://www.avient.com/sites/default/files/resources/Investor%2520Day%2520-%2520May%25202012%2520-%2520Global%2520Engineered%2520Materials.pdf
Nikrant
Page 67
United
States
36%
Europe
36%
Canada
2%
Asia
20%
Latin
America
2011 Revenue: $0.6 Billion2011 Revenue: $0.6 Billion SolutionsSolutions
At a Glance
Global Specialty Engineered Materials
Appliance
6% Building &
Construction
3%
Wire & Cable
14%
Electrical &
Electronics
14%Consumer
21%
Packaging
5%
Industrial
8%
Misc.
3%
HealthCare
5%
Transportation
21%
America
6%
2011 Revenue by Industry Segment2011 Revenue by Industry Segment
1.1%
1.3%
3.4%
5.1%
9.6%
8.0%
12-16%
2006 2007 2008 2009 2010 2011 2015
Operating Income % of Sales
Target
Expanding ProfitsExpanding Profits
Page 68
Value Proposition
• GSEM is a global leader providing complete specialty solutions encompassing
innovative technologies and services to enable customer success
Transformation Highlights
• Dramatic turnaround of the Engineered Materials business through mix
improvement and specialty focus
Value Proposition and Transformation Highlights
Global Specialty Engineered Materials
improvement and specialty focus
• GLS acquisition successfully integrated, having more than
doubled earnings in 3 years
• PolyOne culture and strategy now engrained worldwide
• Expansion into healthcare with dedicated resources
> $15B Addressable Market
Page 69
• Polymer design, formulation and service expertise
• Broad, global technology base and regional centers
of excellence
• Ten innovation centers around the world
Key Differentiators
Global Specialty Engineered Materials
• Ten innovation centers around the world
• Specialty brand leadership with
PolyOne, GLS, NEU and ECCOH
• Ability to leverage global key
account team
Page 70
From Volume
Commodity-driven product portfolio
To Value
Specialty technology and solutions
EM North America Transformation
Volume Sales Gross Margin $
Mix Transformation – Executing the Strategy
Global Specialty Engineered Materials
2006 2011 2006 2011 2006 2011
Page 71
$12
$29
Operating Income
($ in millions)
• Provided access to new customers
in specialized, high-growth markets
such as healthcare and consumer
• Strategic partner to many of the
world’s best-known companies
GLS Integration Success
16.9%
8.2%
2007 2011
2007 2011
Working Capital % of Sales
• Complementary global footprint
provided additional cross-selling
opportunities
• Opportunity to expand margins
and drive working capital
improvement while remaining
customer-focused
Page 72
$1.3
$27.6
2006 2011
Healthcare Revenue
• Investment in dedicated
healthcare team to drive
penetration and growth
• Leverage product portfolio
globally & win specialty business
Areas of Focus
Global Specialty Engineered Materials
$10.5
$117.9
2006 2011
Consumer Revenue
2006 2011globally & win specialty business
in targeted markets
• Aggressively commercialize
specialty innovation platforms
• Utilize our innovation centers to
influence OEM design
(Revenue in $ millions)
Page 73
• Carbon Nanotube Formulations
� Applications: Semiconductor equipment, hard drives
� Customer benefits: Scrap cost reduction and
clean conductivity
• Thermally Conductive Solutions
Applications: Sockets and bulb holders for LED lighting
Key Innovations
Global Specialty Engineered Materials
� Applications: Sockets and bulb holders for LED lighting
� Customer benefits: Cost reduction, energy saving, and
design flexibility
• FDA-Regulated TPEs
� Applications: Food packaging seals, intravenous delivery
systems, medical stoppers, prefilled syringes
� Customer benefits: Clean and safe elastomers for highly
regulated applications
Page 74
Critical Imperatives and 2015 Goal
Global Specialty Engineered Materials
Critical Imperatives
• Commercialize critical new technology platforms
• Manage the mix as we continue to drive
the transformation
• Global translation of commercial successes
2015 Goal
• 12 - 16% return on sales
Page 75
Page 76
https://www.avient.com/sites/default/files/2022-04/Sustainable Material Answers_ Recycled PET 2022.pdf
At Avient, we are proud to be a part of the solution, supporting
the shift from a linear economy to a circular economy and driving
sustainability for all of our stakeholders.
The
expanding beverage market in Asia Pacific
and the ease of bottle-to-bottle recycling
is expected to drive further growth for this
use case.
These commitments and mandates will continue to drive the high and
increasing demand for recycled plastic bottles.
https://www.avient.com/investor-center/news/advanced-composite-materials-polyone-bringing-innovation-and-sustainability-transportation-industry
Composites will play an increasingly larger role in driving our future growth."
https://www.avient.com/investor-center/news/polyone-names-dr-david-jarus-vice-president-research-and-development
Jarus will have global responsibility for driving innovation and developing new solutions and applications across all markets by collaborating with
https://www.avient.com/company/sustainability/sustainability-report/planet/waste
It is this granular information that Avient utilizes to drive improvement projects.
https://www.avient.com/industries/transportation/automotive/automotive-aftermarket
Using LFT not only allows for new product innovation, but often drives reductions in system costs and increases in manufacturing efficiencies.
https://www.avient.com/industries/healthcare/drug-delivery-systems/auto-injectors-and-drug-delivery-pens
The rise in chronic diseases is driving demand for advanced autoinjector solutions, enabling patients to self-administer essential biologics and biosimilars at home with greater convenience and control.